AvenCell CAR-T

Chimeric antigen receptor T cell therapy targeting CD19 · AvenCell Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AvenCell CAR-T, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: Long-Term Follow-Up of AvenCell Sponsored CAR-T Cell Clinical Trials